Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $86.2600 (1.9%) ($84.4700 - $86.9600) on Fri. Feb. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.17% (three month average) | RSI | 48 | Latest Price | $86.2600(1.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.8% a day on average for past five trading days. | Weekly Trend | BAX declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(36%) VYM(35%) SPLV(34%) SDY(33%) XLP(33%) | Factors Impacting BAX price | BAX will decline at least -0.585% in a week (0% probabilities). UUP(-22%) VIXM(-21%) EDOC(-2%) TBT(-1%) VXX(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.585% (StdDev 1.17%) | Hourly BBV | 1.2 () | Intraday Trend | 1.8% | | | |
|
5 Day Moving Average | $84.69(1.85%) | 10 Day Moving Average | $84.83(1.69%) | 20 Day Moving Average | $85.71(0.64%) | To recent high | -3.6% | To recent low | 15.7% | Market Cap | $44.008b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |